Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

15.4K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.4K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

18.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
18.1K
The Two-State Receptor Model01:29

The Two-State Receptor Model

3.3K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.3K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

5.2K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
5.2K
GPCR Desensitization01:12

GPCR Desensitization

8.4K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.4K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

5.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological proximities in the GPCR family discovered using contact-informed amino-acid and binding pocket similarities.

bioRxiv : the preprint server for biology·2026
Same author

Gene expression analyses of TAS1R taste receptors relevant to the treatment of cardiometabolic disease.

Chemical senses·2023
Same author

Q1291H-CFTR molecular dynamics simulations and <i>ex vivo</i> theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient.

Frontiers in molecular biosciences·2023
Same author

Development of Potential Inhibitors for Human T-lymphotropic Virus Type I Integrase Enzyme: A Molecular Modeling Approach.

Current computer-aided drug design·2023
Same author

Computational Evaluation of N-Based Transannular Interactions in Some Model Fused Medium-Sized Heterocyclic Systems and Implications for Drug Design.

Molecules (Basel, Switzerland)·2023
Same author

S945L-CFTR molecular dynamics, functional characterization and tezacaftor/ivacaftor efficacy <i>in vivo</i> and <i>in vitro</i> in matched pediatric patient-derived cell models.

Frontiers in pediatrics·2022

Related Experiment Videos

Template selection and refinement considerations for modelling aminergic GPCR-ligand complexes.

Kaniz F Urmi1, Angela M Finch1, Renate Griffith1

  • 1Department of Pharmacology, School of Medical Sciences, UNSW Australia, Sydney, NSW 2052, Australia.

Journal of Molecular Graphics & Modelling
|August 19, 2017
PubMed
Summary
This summary is machine-generated.

This study developed and evaluated homology modeling methods for G protein-coupled receptors (GPCRs). These accurate models aid drug design for GPCR targets, addressing the lack of available crystal structures for these crucial membrane proteins.

Keywords:
Aminergic GPCRHomology modellingModel evaluationModel refinementSimilarityTemplate selection

Related Experiment Videos

Area of Science:

  • Pharmacology
  • Structural Biology
  • Computational Chemistry

Background:

  • G protein-coupled receptors (GPCRs) are critical drug targets, yet their membrane-bound nature limits available crystal structures.
  • Accurate GPCR homology models are essential for advancing drug design and development.
  • Recent serotonin receptor crystal structures offer potential templates for modeling.

Purpose of the Study:

  • To develop and assess methods for homology modeling, docking, and refinement of aminergic GPCR-ligand complexes.
  • To evaluate the utility of newly solved serotonin receptor structures as modeling templates.
  • To construct and validate homology models for specific GPCR subtypes.

Main Methods:

  • Exploration of template selection similarity measures.
  • Development of homology modeling, docking, and refinement protocols for GPCRs.
  • Validation using the D3 receptor-eticlopride complex against its crystal structure.
  • Construction of homology models for α1 adrenergic and serotonin receptors.

Main Results:

  • Established and validated methods for creating accurate GPCR homology models.
  • Demonstrated the effectiveness of the developed protocols by successfully modeling the D3 receptor.
  • Generated homology models for key adrenergic and serotonin receptor subtypes.
  • Evaluated model accuracy by docking known antagonists.

Conclusions:

  • The developed homology modeling, docking, and refinement strategies provide a robust framework for GPCR drug design.
  • These methods facilitate the creation of reliable structural models for GPCRs lacking experimental structures.
  • The validated models serve as valuable tools for exploring ligand interactions and guiding the development of novel therapeutics targeting GPCRs.